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Strengths and limitations of this study
 ► Using a theory- driven realist evaluation approach, 
findings from this study are expected to generate 
contextually relevant evidence for other care coor-
dination systems.
 ► The study will test and refine these theories using a 
mixed methods approach, enhancing the credibility 
of the evaluation findings.
 ► This study addresses the need for qualitative re-
search into the use of EPaCCS, offering much need-
ed insight into patient and carers’ experiences of 
EPaCCS.
 ► The study will investigate the impact of only one of 
the many EPaCCS developed and implemented in 
the UK.
 ► The qualitative component has a potentially small 
sample size; however, the aim of the study is not to 
find a robust causal mechanism for EPaCCS, but to 
unpack the contexts and mechanisms that work in 
certain circumstances.
AbStrACt
Introduction Electronic palliative care coordination 
systems (EPaCCS) aim to support people approaching 
the end of life (EOL) to receive consistent care, according 
to their wishes, that is coordinated effectively across 
multiple care sectors. They are in use across the UK 
although empirical evidence into their effectiveness is 
poor. This paper presents a protocol of a mixed- methods 
study, to understand how, and by whom, EPaCCS are 
being used and whether EPaCCS are enabling Healthcare 
Professionals (HCPs) to coordinate patients’ EOL care.
Methods and analysis This is a mixed- methods study, 
carried out within a realist paradigm, to evaluate the 
impact of an EPaCCS on EOL care as provided by a Clinical 
Commissioning Group (CCG) in England. This study has two 
aims: (1) Describe the socio- demographic characteristics 
of patients who die with an EPaCCS record, their 
underlying cause of death and place of death and compare 
these with patients who die without an EPaCCS record. 
(2) Explore the impact of an EPaCCS on the experience 
of receiving EOL care for patients and their carers, and 
understand HCPs’ views and experiences of utilising an 
EPaCCS to coordinate care for their patients. The study will 
be conducted in five phases: (1) development of the initial 
programme theory; (2) focus group with CCG stakeholder 
board; (3) individual interviews with HCPs, patients, current 
and bereaved carers; (4) retrospective cohort study of 
routinely collected data on EPaCCS usage and (5) data 
analysis and synthesis of study findings.
Ethics and dissemination The study has been approved 
by National Health Service South West–Frenchay Research 
Ethics Committee (REC reference number: 18/SW/0198). 
Findings will be published in a wide range of outputs 
targeted at key audiences.
bACkground
People at the end- of- life (EOL; taken here to 
mean in the last 12 months of life) frequently 
receive care from a wide variety of teams and 
organisations. Much of this care is accessed 
in the out- of- hours period (overnight and at 
the weekend), when they are unlikely to see 
a healthcare professional (HCP) who knows 
them well. Out- of- hours provision of pallia-
tive care (defined by the National Institute for 
Health and Clinical Excellence (NICE) as ‘the 
active holistic care of patients with advanced, 
progressive illness’1) has been identified as 
a key priority for future research by the Palli-
ative and End of Life Care Priority Setting 
Partnership, initiated in 2013 by Marie Curie.2 
This process identified the top 10 unanswered 
research questions and the question with the 
highest priority was, ‘What are the best ways 
of providing palliative care outside of working 
hours to avoid crises and help patients to stay in 
their place of choice?’
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Figure 1 Definition of context, mechanism and outcome.
Continuity of care is important for anyone with complex 
health and social care needs, but particularly for those at 
EOL.3 Until recently HCPs have communicated patients’ 
EOL care plans, to other HCPs, by means of a variety of 
methods, including shared EOL care registers, letters, faxes 
and telephone and/or face to face conversations. Despite 
this, a lack of information sharing has been repeatedly 
cited as a barrier to the provision of good quality EOL care 
outside of normal working hours.4–6 Recent studies looking 
at the experiences and needs of people seeking palliative 
care out- of- hours found that most patients expect the HCP 
to be able to access a summary of their complex medical 
history and many voiced concerns that their full record 
could not be accessed by out- of- hours clinicians.5 7 For 
some patients, lack of access to their notes is a deterrent to 
accessing care out- of- hours.6
Nationally, the policy drive to address the issue of 
information continuity has resulted in the development 
of Electronic Palliative Care Coordination Systems, or 
EPaCCS.5 8–10 These records are usually completed by the 
patients’ general practitioner (GP) or community nurse, 
including patients’ advance care wishes, and are accessible 
across multiple care sectors.10 The purpose of EPaCCS is 
to provide a shared local record for health and social care 
professionals, with key information about an individual 
approaching the EOL, including their expressed prefer-
ences for care. In accordance with the Quality Statements in 
the NICE End of Life Care Standard for Adults,11 the intent 
is for EPaCCS to support people approaching the EOL to 
receive consistent care that is coordinated effectively across 
all relevant settings.
An EPaCCS record can take various forms, including 
web- based electronic registers, systems based on sharing 
care summaries or care plans, alongside patients’ elec-
tronic records. They store a dynamic record of a patient’s 
medical condition, treatment, wishes and preferences, 
and provide information about the medication a patient is 
receiving, contact details of any carers and services involved 
in providing care and support to the patient.
Sharing information about patients’ EOL care has the 
potential to improve coordination and communication 
across care settings.12 It may reduce the chance of emer-
gency department attendance, hospital admission and 
dying in hospital.8 13
It is now recognised that place of death is unlikely to be 
the most important factor in achieving a good death and 
a recent UK study has proposed that it is the presence of 
loved ones that is more important than the physical loca-
tion.14 However, death in preferred place remains a signif-
icant measure of quality of death15 and, according to the 
Voices survey of bereaved people, despite 81% of respon-
dents believing that the deceased had wanted to die at 
home less than a quarter of people actually achieve this.16 17
Quantitative studies have shown striking differences 
in place of death with EPaCCS but are potentially biased 
and confounded.12 A more recent study challenges these 
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Table 1 Programme theory for the EPaCCs study, comprising the 17 CMO statements that inform the programme theory, and 
the questions that will be used, in the focus group with the end- of- life board, to investigate each CMO statement
EPaCCs process CMOs Focus group questions
Commissioning 1. If the strategy behind the EPaCCs is definable, 
deliverable and measureable, the aim, purpose and 
outcomes of EPaCCS will be clear. (strategy)
 ► How will you evaluate EPaCCS success?
 ► What are the markers of success for you?
 ► What is the CCGs long term vision for the EPaCCS?
2. If HCPs engage with the EPaCCS positively on 
early usage and see it as an improvement on any 
previous EOL register, HCPs will engage positively 
with EPaCCS. (engagement)
 ► Given that the previous EOL register was generally not 
well thought of, or used, how did the CCG plan to get 
HCPs on board?
 ► How do you think the EPaCCS has been received?
Commissioning/uptake/adoption 3. If the EPaCCS is well- publicised and marketed 
to all stakeholders HCPs will be aware of EPaCCS, 
understand the aim and purpose of the EPaCCS, 
and will initiate an EPaCCs template and/or access 
an EPaCCS record. (publicity)
 ► How was the EPaCCS publicised and marketed to 
different groups of HCPs? What are your views on 
how effective this has been?
 ► How aware do you think HCPs are of EPaCCS 
and do you think they understand its purpose and 
importance?
4. If HCPs receive sufficient support and training, so 
that they know how to use it, they and will initiate 
an EPaCCs template and/or access an EPaCCS 
record. (training)
 ► Can you tell us about the CCG strategy for providing 
training and support to different groups of HCPs in the 
EPaCCS roll- out?
 ► What do you think about this, and how effective it has 
been?
Uptake/adoption 5. If HCPs have the time and/or resources to learn a 
new system, an EPaCCS template will be initiated. 
(time and resources)
 ► There are a significant number of GP practices that 
have not initiated an EPaCCS – do you have any 
thoughts about why this might be?
 ► Do you think all HCPs will have the time and resources 
(ie, they are connected to a computer, have internet 
and NHS network access) to learn and new system 
and access EPaCCS?
6. If HCPs are incentivised to use EPaCCS, an 
EPaCCS template will be initiated. (incentives)
 ► Do HCPs have other ways of obtaining the information 
contained on EPaCCs?
 ► What might these be, and are these ways better or 
worse, more reliable or less reliable?
Uptake 7. If the patient consents to information- sharing and 
storage of information about their care preferences, 
an EPaCCS template will be initiated. (information 
sharing)
 ► For the EPaCCS to be effective, patients must 
consent to information- sharing, and the storage of 
information.
 ► Did you anticipate that this would raise any issues?
8. If HCPs are near to a computer, are connected 
to the internet and have access to the GP EMIS 
Web record, an EPaCCS template will be initiated. 
(access to system)
 ► There is a theory that because EPaCCS is an 
electronic record, presently only updateable by the 
GP on EMIS Web, that this will have an impact on the 
ability of others to access it and update it and own it. 
Do you see this as an issue?
 ► What impact do you think this might present?
9. If HCPs feel able/comfortable having ACP 
conversations with patients, an EPaCCS template 
will be initiated. (ACP conversations)
 ► How do you think HCPs feel about having ACP 
conversations with patients?
 ► Research suggests that patients with non- malignant 
diagnoses are less likely to be added to EPaCCS.
 ► Do you think this is the case and if so why? Are there 
other patient groups who might be under- represented 
on the EPaCCS?
10. If HCPs feel that the EPaCCS facilitates, 
potentially difficult, ACP conversations an EPaCCS 
template will be initiated. (ACP conversations)
 ► Some would argue that the EPaCCS template might 
facilitate ACP conversations with patients–what are 
your thoughts on this?
11. If the patient is willing, and has capacity to have 
ACP conversations, an EPaCCS template will be 
initiated. (ACP conversations)
 ► Patients can only record their wishes if they are able to 
have a conversation with an HCP–what issues do you 
think this might present?
Adoption 12. If End of Life Care information about a patient 
can be accessed more efficiently in other ways 
(ie, speaking with carer or reading other sources 
of information) the information on the EPaCCS 
template may not be accessed. (single point of 
access)
 ► Are there any other sources of information that HCPs 
might access to establish the EOL wishes and needs 
of a patient and do you think they present an issue of 
the uptake of EPaCCS?
13. If HCPs are near to a computer, are connected 
to the internet and have access to the NHS Network 
an EPaCCs template will be accessed. (access to 
system)
 ► There is a theory that because EPaCCS is an 
electronic record, presently only updateable by the 
GP on EMIS Web, that this will have an impact on the 
ability of others to access it and update it and own it.
 ► Do you see this as an issue? What impact do you 
think this might present?
Continued
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Figure 2 Visual representation of the initial programme theory at a macro level. ACP, advanced care planning; EPaCCS. 
electronic palliative care coordination systems.
EPaCCs process CMOs Focus group questions
Adoption/care coordination 14. If the information does not reflect the current 
wishes of the patient, care may not be aligned with 
the patients’ preferences. (patient preferences)
 ► Do you feel that the EPaCCs adequately reflects 
patient’s wishes and preferences for care?
15. If the patient does not have clear or clinically 
meetable preferences, or their wishes are subject to 
frequent change, care may not be aligned with the 
patient’s wishes. (patient preferences)
 ► Do you feel the EPaCCS adequately reflects the 
patient’s/carer’s wishes and preferences regarding 
end of life care and do you feel these wishes are 
deliverable? If not, why might this be and what needs 
to be improved?
Care coordination 16. If HCPs access EPaCCS and consider the 
information contained within it to be trustworthy 
(current, relevant, detailed and useful) care will be 
coordinated by EPaCCs and this care will align with 
the patient’s wishes. (trustworthiness of EPaCCS)
 ► Do you think the EPaCCS contains all the information 
HCPs need to enact their patient’s wishes and 
coordinate their patient’s care?
 ► Do you consider it to be current, relevant, detailed and 
useful? If not, why might this be and what needs to be 
improved?
17. If EPaCCS does not enhance or improve the 
care that is already being delivered care may not be 
coordinated by EPaCCS, consistent or reflect the 
patients’ preferences. (patient outcomes)
 ► What are your thoughts on the notion that: ‘The 
EPaCCS is not coordinating care, it is simply recording 
what is already being done’
ACP, advanced care planning; CCG, Clinical Commissioning Group; CMO, context, mechanism and outcome; EOL, end of life; EPaCCS, electronic palliative care 
coordination systems; GP, general practitioner; HCP, healthcare professional; NHS, National Health Service.
Table 1 Continued
assumptions, suggesting that the increase in home deaths 
could in fact be due to selection bias (few secondary care 
colleagues used the systems and therefore hospital deaths 
are not captured).10 The findings of this study also under-
score the importance of qualitative approaches, which can 
offer crucial insights into what is happening on the ground, 
away from broad claims of EPaCCS benefits arrived at solely 
through quantitative methods. Without understanding 
the experiences of patients and carers, together with the 
perspectives of HCPs, it is difficult to evaluate the effective-
ness of EPaCCS.18
Technology in isolation is not guaranteed to bring 
benefit and the initiation of an EPaCCS relies on HCPs 
initiating conversations about death and dying. There is 
evidence that these conversations are difficult for HCPs,19 
with many choosing to avoid the conversation altogether.20 
What impact EPaCCS has on these conversations, if any, is 
not clear.
A recent independent evaluation of EPaCCS found that 
‘it was not possible to demonstrate that EPaCCS was making 
any difference to the care patients were receiving at EOL 
because the range of clients for whom EPaCCS was being 
used remains focused on cancer, and the ability of EPaCCS 
systems to report on progress and outcomes remains gener-
ally poor.’21
We therefore do not know if EPaCCS acts to improve 
practice or whether it simply documents and reflects what is 
already taking place in practice.21 Indeed, the need to gather 
evidence of effectiveness of EPaCCS is vitally important, as 
it has already been widely and uncritically adopted by the 
National Health Service (NHS).
To summarise, very little research has been carried out 
to understand how, and by whom, EPaCCS are being used 
and, perhaps more importantly, whether EPaCCS are 
enabling HCPs to support patients’ EOL wishes. Rigorous 
evaluation and research are urgently needed to investigate 
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to what extent EPaCCS influence services working together 
to support ‘a good death’, the outcome that stakeholders 
think is of most importance.22
AIMS, objECtIvES And rESEArCh quEStIonS
The study has two aims. These are to:
1. Describe the socio- demographic characteristics of pa-
tients who die with an EPaCCS record, their underly-
ing cause of death and place of death and compare 
these with patients who die without an EPaCCS record.
2. Explore the impact of an EPaCCS on the experience of 
receiving EOL care for patients and their carers, and 
understand HCPs’ views and experiences of utilising 
an EPaCCS to provide palliative care to their patients.
ProjECt MEthodology
Study setting
This study will be implemented in England, where one 
Clinical Commissioning Group (CCG) has recently devel-
oped and rolled out an EPaCCS. This involved the dissem-
ination of an EMIS Web template, which was circulated 
to general practices, to help ensure consistent data entry 
and coding. EMIS Web is the most widely used primary 
care clinical system in the UK and allows real- time patient 
information to be shared securely between different 
organisations. All practices in the CCG area are EMIS 
Web users and it is now also used by the local hospice and 
many of the community nursing teams.
The EPaCCS template was developed following exten-
sive local clinical consultation and the National Informa-
tion Standard.23 Although some organisations within the 
CCG area (ambulance service, secondary and social care) 
are non- EMIS Web users, information from the EPaCCS 
template can be viewed across the local health community, 
via the integrated digital care record used by health and 
social care professionals in the CCG area which went live 
at the end of February 2018. The integrated digital care 
record contains some of the information held at GP prac-
tices, hospital departments, community services, mental 
health trusts, out of hours services and local authorities 
across the CCG area, combining it into a single, shared 
digital record.
Conceptual framework
This study will draw on a realist evaluation approach.24 A 
randomised, experimental study design is not possible as 
the implementation of EPaCCS has been strongly advo-
cated and promoted by NHS England, with 83% of CCGs 
in England reported to have an operational EPaCCS, 
or be in the planning stages, by 2013.25 The CCG had 
recently operationalised an EPaCCS at the time of study 
design.
By their nature, EPaCCS involve multiple organisa-
tions and a multidisciplinary style of work. It therefore 
requires a novel methodological approach to evaluation 
as described in this protocol.
Realist evaluation is a theory- driven approach designed 
for evaluating complex interventions, such as EPaCCS, 
where the outcomes are influenced by the way the inter-
vention is delivered and in what context. Due to this 
complexity, any evaluation of EPaCCS seeking to deter-
mine linear causal relationships or simply find out if the 
intervention ‘works’ is unlikely to be useful. Pawson and 
Tilley,24 the developers of realistic evaluation, suggest 
that the results of an intervention (outcomes) are depen-
dent on the introduction of appropriate reasoning and 
resources (mechanisms) and how these then interact 
with existing social and cultural condition (contexts). For 
the purposes of this study, we have defined context (C), 
mechanism (M) and outcome (O) in figure 1.
A realist approach acknowledges that complex inter-
ventions only ever work for certain people, in particular 
circumstances. The key task of a realist evaluation is to 
understand and explain these patterns by asking the 
exploratory question: what works, for whom and in what 
circumstances?
According to Pawson, interventions or ‘programmes’, 
such as the EPaCCS, are ‘theories incarnate’ and every 
programme has a theoretical underpinning.26 Before 
conducting a realist evaluation, the researchers must 
develop a theory, or theories, that explain what works, for 
whom, under what circumstances and how. This is some-
times known as the ‘initial programme theory’ and is 
described through CMO conjectures. This theory, or theo-
ries, are then tested through the process of the evaluation.
The study will be conducted in five phases: (1) devel-
opment of the initial programme theory; (2) focus group 
with CCG stakeholder board; (3) individual interviews with 
HCPs, patients, current and bereaved carers; (4) retrospec-
tive cohort study of routinely collected data on EPaCCS 
usage and (5) data analysis and synthesis of study findings.
Phase 1: development of the initial programme theory (june–
october 2018)
Phase 1 is complete and included identification of relevant 
literature from electronic searches of databases, such as 
Medline and Google Scholar. The search strategy involved 
searching for papers which discussed or evaluated shared 
digital records, for the coordination of palliative care, EOL 
care or advance care plans. Reference lists of relevant papers 
were scanned, and citation searches conducted. Grey liter-
ature relating to policy and organisational- based material 
were sought by searching government and other specialist 
websites. The lead researcher’s own experiences as a GP 
were used as ‘informed guesswork’27 and initial meetings 
were held with key stakeholders, including patients at the 
local hospice and commissioners. These initial engage-
ments were informal and were patient and public involve-
ment activities (detailed further below). They did not 
constitute formal interviews requiring ethics clearance.
The proposed implementation of EPaCCs was broken 
down and analysed, to understand different elements of 
this process (table 1, column 1). These elements, high-
lighted as important through literature searches and initial 
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stakeholder engagement, were analysed and detailed into 
initial CMO statements (table 1, column 2). An overview 
of these CMO statements were then illustrated through a 
process diagram as illustrated in figure 2.
At an early stage of the programme theory development, 
the CMO conjectures were reviewed by, and discussed with, 
Dr Justin Jagosh, Director of the Centre for Advancement 
in Realist Evaluation and Synthesis.
The initial programme theory forms a set of hypotheses 
on what the mechanisms may be, what groups may benefit 
most or least and the contextual factors that might be 
important to its success or failure. These hypotheses will be 
interrogated and tested in phases 2–5 of the study.
Phase 2: focus group with CCg stakeholder board (october 
2018)
The CCG EOL care board is a multi- disciplinary, multi- 
organisational system board, whose members are high- 
level stakeholder representatives from across the CCG, 
including representatives from community nursing 
teams, primary care, the ambulance service (which serves 
a wider geographical area than the CCG area), local 
hospices, care homes and secondary care. The purpose of 
the board is to review the current commissioning across 
all geographical provision, ensuring unified pathways for 
community, primary and secondary providers to provide 
consistency for all patients, carers and staff across the 
system.
Board members will be invited to take part in a focus 
group following their attendance at the monthly board 
meeting. Focus groups allow for social interaction which 
can help to reveal issues and subsequent points of view 
that may not be prompted or discovered through indi-
vidual interviews. This approach will help the study 
team to gain as wide an understanding as possible of the 
process of commissioning the EPaCCS and help to refine 
the initial programme theory.
Participants will be consented to take part in the study 
prior to the focus group by either LF or LP who will be 
facilitating. A topic guide will be used to steer the focus 
group and will enable the research team to test and refine 
the initial programme theory prior to commencing the 
in- depth interviews (see table 1).
It is anticipated that the focus group will last approxi-
mately 45 min and that approximately 5–10 participants 
will take part in it. The focus group will be audio taped 
and transcribed verbatim.
Phase 3: individual interviews with hCPs, patients, current 
and bereaved carers (november 2018–july 2019)
Healthcare professionals
HCPs from community nursing teams, primary care, the 
ambulance service, the local hospices, care homes and 
secondary care will be invited to participate.
GPs working in practices within the CCG area will be 
invited to support the study and the study team will purpo-
sively sample from a list of practices, to include practices 
that are high- users of EPaCCS and low users of EPaCCS 
based on data compiled by the CCG.
The research team will purposively sample HCPs who 
express an interest in participating according to gender, 
age and profession to ensure maximum variation in the 
sample. All interviews with HCPs will take place over the 
telephone for both pragmatic and methodological reasons. 
Conducting interviews over the telephone will reduce the 
time and cost to the study that may be involved in travelling 
to interviews and well- planned telephone interviews can 
gather the same material as those held face to face.28
A topic guide, informed by the evolving programme 
theory, will be used to ensure consistency across the inter-
views. This will enable the research team to compare the 
views of each group at the stage of data analysis. Interviews 
will last approximately 30 min and it is anticipated that 
approximately 3–5 HCPs will be interviewed from each 
group (18–30 in total).
Patients, current and bereaved carers
Patients will be approached to take part in interviews 
through their GP surgeries or the local hospice. The 
research team will purposively sample from a list of prac-
tices, to include practices that are high- users of EPaCCS 
and low users of EPaCCS. High EPaCCS use will be 
defined as practices that have created greater than 20 
EPaCCS records (the median number of records across 
all practices) 4 months post- implementation, based on 
data extracted by the CCG. Selected practices will be 
asked to identify patients, aged 18 and over, receiving 
EOL care, who they consider might be eligible to take 
part in the study.
Inclusion criteria
1. Capacity to give informed consent.
2. Aged 18 and over.
3. Prognosis 12 months or less as identified by their GP 
(patient aware of this prognosis).
Potential participants will be sampled purposively to 
include patients across the age range, with and without an 
EPaCCS record, with both malignant and non- malignant 
health conditions.
To recruit patients to the study from the local hospice 
we will liaise with key clinical staff, who will be respon-
sible for identifying appropriate patients. Once again, 
potential participants will be sampled purposively to 
include patients across the age range, with and without an 
EPaCCS record, with both malignant and non- malignant 
health conditions.
Alongside their own study information pack, all patients 
will be given a carer information pack which they can 
choose to give to their carer if they are happy for their 
carer to participate in the study.
GPs will also be asked to identify recently bereaved 
carers (between 8 weeks and 6 months of the death of 
their relative), who they consider might be eligible to 
take part in the study. GPs will be sent details of how to 
perform an appropriate search within EMIS Web to iden-
tify potential participants.
Interviews with carers will be conducted one- to- one with 
the interviewer. Interviews with patients will be conducted 
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either one- to- one with the interviewer or in the presence 
of their carer, according to the wishes of the patient.
Interviews will last approximately 45 min and it is antic-
ipated that approximately 15 patients will be interviewed 
(10 EPaCCS patients and 5 non- EPaCCS patients) and 10 
carers (to include both current and bereaved). All inter-
views will be audio taped and transcribed verbatim.
Phase 4: retrospective cohort study of routinely collected data 
on EPaCCS usage (March 2019–july 2019)
EMIS Web data will be accessed to identify all patients, 
aged 18 and over, who die in the CCG area between 22 
February 2018 and 21 February 2019. Agreements are in 
place with the CCG to obtain this data. Patients will be 
identified as either having an EPaCCS record (EPaCCS 
patient) or not (non- EPaCCS patient), using EMIS Web 
coding.
EMIS Web will be used to characterise both EPaCCS 
and non- EPaCCS patients in terms of their gender, 
ethnicity and postcode (as a proxy for socio- economic 
status according to their Index of Multiple Deprivation 
Score). Data will be extracted to describe:
1. The proportion of patients that die with an EPaCCS 
record.
2. When the EPaCCS record is initiated (ie, how many 
months/days prior to the patient’s death), and by 
whom.
3. How frequently the EPaCCS record is updated once 
opened, and who makes any changes.
4. The underlying cause and place of death for EPaCCS 
and non- EPaCCS patients.
5. The number of hospital admissions and Emergency 
Department attendances for EPaCCS and non- EPaCCS 
patients in the last 12 months of life.
Descriptive data will be collected, by the CCG, on 
EPaCCS usage, including the number of records created 
by each GP surgery in the CCG area. Data from the inte-
grated digital care record will be accessed to describe 
which HCPs (GPs, community nurses, hospice HCPs, 
ambulance HCPs and secondary care clinicians) are 
accessing these shared EOL care records.
Phase 5: data analysis and synthesis of study findings 
(october 2018–october 2019)
Quantitative methods
Quantitative data will be analysed using Stata V.15 and 
reported using descriptive statistics. Within the context 
of this realist evaluation, we were keen to use the quanti-
tative data to address a single hypothesis, namely whether 
nominal possession of an EPaCCS record was associated 
with increased chance of dying at home. However, logistic 
regression will be used to determine the adjusted OR and 
95% CI for the associations between having an EPaCCS 
record and dying at home, considering other factors of 
interest, including, but not limited to: age, sex, depriva-
tion and underlying cause of death.
Of approximately 8000 deaths occurring in the CCG 
area over the year of study, we expect around 10% (800 
deaths) of patients to have an EPaCCS.10 If the propor-
tion of deaths occurring at home is expected to be 25% 
among those without an EPaCCS, we would have over 
99% power to detect an absolute increase of 10% to 35% 
among those with an EPaCCS. The power would be about 
84% if the proportion were increased by 5% to 30%.
Descriptive statistics will be employed to report EPaCCS 
usage.
Qualitative methods
Data analysis will be conducted using a realist approach 
informed by Jackson and Kolla’s realistic evaluation 
analysis method.29 This analytic process will involve the 
following steps:
1. Coding individual units (a discrete C, M or O) within 
the narratives of the interviews.
2. Identifying the complex connections that link these 
codes together into dyads or triads.
3. Subsuming the linked codes into themes using themat-
ic analysis.30
Analysis will begin shortly after data collection starts 
and be ongoing and iterative. Analysis will inform further 
data collection: for instance, analytic insights from data 
gathered in earlier interviews will be used to develop 
and adapt the programme theory and in turn, identify 
any changes that need to be made to the topic guide for 
use during later interviews. The study will generate new 
programme theories to explain how the EPaCCS works, 
for whom and any contextual influences and constraining 
factors that affect their initiation and usage. Emerging 
analysis and findings will be discussed with PPI represent-
atives, to explore and clarify findings.
Qualitative and quantitative data will be collected 
concurrently, giving equal weight to each.30 Data will be 
triangulated in order to test and refine the programme 
theories, accepting that any findings are fallible and with 
time and further study new data are bound to emerge.31 
The synthesised study findings will establish the poten-
tial outcomes of EPaCCS, identify the underlying mech-
anisms which explain how they produce these effects 
and highlight the key contextual factors that affect their 
success or failure. Recommendations can then be made 
for the development and implementation of EPaCCS.
Patient and public involvement
To support the development of this study protocol, 
members of the study team (LF and LP) presented and 
discussed an outline proposal of this study to patients, 
staff and carers at the local hospice on two separate occa-
sions in April 2018. Approximately 10 participants volun-
tarily took part in these, semi- structured, discussions, in 
which we asked specific questions concerning ethical and 
methodological issues. Participants were also encour-
aged to ask any questions. These meetings raised several 
important issues which have been incorporated into 
the design of this study. Such issues included allowing 
patients the choice of whether to have a carer sit along-
side them during their interview and which HCPs they 
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felt it was important that the study team spoke to, due to 
the involvement they had in providing care for patients. 
The meetings also discussed what terms, wording and 
questions would be acceptable to patients and carers to 
read and hear in the study information documents and 
interviews.
At the end of both meetings, patients and carers 
were invited to continue to support the design of the 
study should they wished. Two members came forward 
expressing a wish to be more actively involved in the 
study. They have kindly been involved in reviewing all the 
study literature, including the topic guides, study infor-
mation sheets and the lay summary for this protocol. It is 
hoped that they will wish to continue their involvement 
with the study. This will include informing the content 
of materials for lay audiences, drawing links to groups 
and forums that the research team may be unaware of, 
and supporting the study team with the interpretation 
and dissemination of study findings. To ensure ongoing 
PPI, all patients and carers taking part in the study will be 
invited to support the ongoing development of the study.
Ethics and dissemination
The study has been approved by NHS South West–
Frenchay Research Ethics Committee (REC reference 
number: 18/SW/0198). The research team will dissemi-
nate the findings to a range of stakeholders. We will draw 
on the networks and expertise of the local CCG EOL 
care board to disseminate the research outputs widely 
and appropriately. Key audiences include patient and 
carer organisations, GPs and community nursing teams 
in primary care, ambulatory services and care home 
staff, HCPs working in secondary palliative care services 
and hospices, managers and directors within healthcare 
organisations with responsibility to provide high- quality 
services within budget and healthcare policy- makers, 
nationally and internationally.
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